Home / Feed aggregator / Sources / Yahoo! News Search Results for chronic constipation
STAMFORD, Conn., Sept. 9 /PRNewswire/ -- Purdue Pharma L.P. will present data from the clinical program for Butrans(TM) (buprenorphine) Transdermal System CIII in a series of posters at PAINWeek® 2010, September 8-10 in Las Vegas. Butrans recently received marketing approval from the U.S. Food and Drug Administration and is expected to be commercially available in the U. S. during the first ...
Categories: Chronic Constipation News
STAMFORD, Conn.--(BUSINESS WIRE)--Purdue Pharma L.P. will present data from the clinical program for Butrans™ (buprenorphine) Transdermal System CIII in a series of posters at PAINWeek®2010, September 8-10 in Las Vegas. Butrans recently received marketing approval from the U.S. Food and Drug Administration and is expected to be commercially available in the U. S. during the first quarter of 2011 ...
Categories: Chronic Constipation News
Scientists at the UK's National Physical Laboratory have developed a new strategy for quicker and more precise detection of biomarkers - proteins which indicate disease. The work could pave the way for new tools to detect early stages of Alzheimer's and cancer at the molecular level.
Categories: Chronic Constipation News
Teens deal with weight perceptions and eating disorders.
Categories: Chronic Constipation News
Communication could be the riskiest procedure in medicine.
Categories: Chronic Constipation News
Progenics Pharmaceuticals Inc. Posted on:08 Sep 10 Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced the initiation of an international 700-patient, phase 3 trial of oral methylnaltrexone in patients with chronic, non-cancer pain who are experiencing constipation as a result of their opioid-pain management regimens.
Categories: Chronic Constipation News
Progenics Pharmaceuticals, Inc. today announced the initiation of an international 700-patient, phase 3 trial of oral methylnaltrexone in patients with chronic, non-cancer pain who are experiencing constipation as a result of their opioid-pain management regimens. The goal of the study is to evaluate the safety and efficacy of oral methylnaltrexone to treat opioid-induced constipation (OIC) in ...
Categories: Chronic Constipation News
TARRYTOWN, N.Y.--(BUSINESS WIRE)--Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced the initiation of an international 700-patient, phase 3 trial of oral methylnaltrexone in patients with chronic, non-cancer pain who are experiencing constipation as a result of their opioid-pain management regimens. The goal of the study is to evaluate the safety and efficacy of oral methylnaltrexone ...
Categories: Chronic Constipation News
Researchers from Mount Sinai School of Medicine have discovered a major mechanism underlying the development of tolerance to chronic morphine treatment. The discovery may help researchers find new therapies to treat chronic pain, and reduce tolerance and side effects associated with morphine use. The findings are published in the July 20th issue of Science Signaling. Overcoming tolerance to ...
Categories: Chronic Constipation News
Washington, Sept 8 : Mount Sinai researchers have discovered a major mechanism underlying the development of tolerance to chronic morphine treatment – the find might lead the way for new therapies to treat chronic pain.
Categories: Chronic Constipation News
Researchers from Mount Sinai School of Medicine have discovered a major mechanism underlying the development of tolerance to chronic morphine treatment. The discovery may help researchers find new therapies to treat chronic pain, and reduce tolerance and side effects associated with morphine use. The findings are published in the July 20th issue of Science Signaling.
Categories: Chronic Constipation News
There are so many medications out there to treat acid reflux, but how do you know which one is right for your condition? We talked to a specialist to find out.
Categories: Chronic Constipation News
Researchers have discovered a major mechanism underlying the development of tolerance to chronic morphine treatment.
Categories: Chronic Constipation News
( The Mount Sinai Hospital / Mount Sinai School of Medicine ) Researchers from Mount Sinai School of Medicine have discovered a major mechanism underlying the development of tolerance to chronic morphine treatment.
Categories: Chronic Constipation News
Researchers from Mount Sinai School of Medicine have discovered a major mechanism underlying the development of tolerance to chronic morphine treatment. The discovery may help researchers find new therapies to treat chronic pain, and reduce tolerance and side effects associated with morphine use. The findings are published in the July 20th issue of Science Signaling.
Categories: Chronic Constipation News
Many medicines taken by mouth may affect the digestive system. These medicines include prescription (those ordered by a doctor and dispensed by a pharmacist) and nonprescription or over-the-counter products. Although these medicines usually are safe and effective, harmful effects may occur in some people. In fact many people not only suffer, but start taking another medicine to address the ...
Categories: Chronic Constipation News
NEW YORK — Oklahoma City bomber-helper Terry Nichols, serving a life sentence at the “Super Max” federal prison in Colorado, recently ended what he said was his third hunger strike of 2010 to protest food quality.
Categories: Chronic Constipation News
There are plenty of colorful ways to describe a bowel movement: Number two, log rolling, sinkers and floaters. For some kids, though, this normal bodily function can be anything but a smooth move.
Categories: Chronic Constipation News
RALEIGH — North Carolina’s Department of Agriculture has issued a warning that cases of Equine Piroplasmosis have been recently found in North Carolina.
Categories: Chronic Constipation News
